Ghost Tree Capital, LLC / SNDX
Ghost Tree Capital, LLC’s Syndax Pharmaceuticals Inc Position
Does Ghost Tree Capital, LLC own Syndax Pharmaceuticals Inc (SNDX)? Yes — 450.0K shares worth $9M (+2.62% of its 13F portfolio) as of Q3 2024, up from 350.0K shares the prior filed quarter.
Position Value
$9M
Q3 2024
Shares
450.0K
% of Portfolio
+2.62%
Quarters Held
18
currently held
Position History SNDX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2024 | 450.0K | $9M | +2.62% |
| Q2 2024 | 350.0K | $7M | +2.25% |
| Q1 2024 | 150.0K | $4M | +0.99% |
| Q3 2023 | 200.0K | $3M | +0.96% |
| Q2 2023 | 350.0K | $7M | +2.42% |
| Q1 2023 | 325.0K | $7M | +2.03% |
| Q4 2022 | 150.0K | $4M | +1.63% |
| Q3 2022 | 200.0K | $5M | +1.35% |
| Q2 2022 | 225.0K | $4M | +2.25% |
| Q1 2022 | 225.0K | $4M | +0.85% |
| Q4 2021 | 300.0K | $7M | +2.35% |
| Q3 2021 | 575.0K | $11M | +3.21% |
| Q2 2021 | 875.0K | $15M | +4.13% |
| Q1 2021 | 1.18M | $26M | +6.17% |
| Q4 2020 | 1.35M | $30M | +6.69% |
| Q3 2020 | 425.0K | $6M | +1.81% |
| Q2 2020 | 185.0K | $3M | +0.72% |
| Q1 2020 | 250.0K | $3M | +0.73% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of SNDX.